Fund Holdings — Redmile Group, LLC

Total Portfolio Value:
$1.37B
Total Bought:
$229.88M
Total Sold:
$307.53M
Net Transaction:
-$77.65M
Notable People:
Jeremy Charles Green, Joshua Damian Garcia, Bryan Ranney Crapo, Michael Stewart Lee, Robert Carrington Faulkner, Travis John Breznak
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Nurix Therapeutics, Inc.(NRIX)4,073,7877,901,085+3,827,298$98.83M$187.33M13.71%+$88.50M
Krystal Biotech, Inc.(KRYS)632,005527,684-104,321$234.90M$175.49M12.84%-$59.41M
Scholar Rock Holding Corporation(SRRK)4,311,0923,033,962-1,277,130$237.11M$146.60M10.73%-$90.51M
Stoke Therapeutics, Inc.(STOK)3,945,9203,869,028-76,892$129.11M$100.59M7.36%-$28.52M
Immunome, Inc.(IMNM)4,911,5904,363,064-548,526$104.08M$93.85M6.87%-$10.23M
Absci Corporation6,739,6756,671,377-68,298$78.11M$71.85M5.26%-$6.26M
Electra Therapeutics Inc05,430,918+5,430,918$0$61.10M4.47%+$61.10M
Annexon Inc11,869,87714,278,075+2,408,198$67.78M$60.40M4.42%-$7.38M
Neurogene Inc1,412,1991,562,199+150,000$44.41M$43.46M3.18%-$953.3K
Regenxbio Inc4,368,8045,048,502+679,698$52.34M$38.02M2.78%-$14.32M
Shattuck Labs Inc6,892,0335,086,990-1,805,043$47.83M$34.69M2.54%-$13.14M
Fate Therapeutics Inc12,872,94612,872,9460$34.76M$30.51M2.23%-$4.25M
Silence Therapeutics plcADS(SLN)2,164,7772,460,894+296,117$23.77M$26.90M1.97%+$3.13M
Beam Therapeutics Inc.(BEAM)1,164,2591,061,782-102,477$39.96M$25.96M1.90%-$14.00M
Attovia Therapeutics Inc01,163,587+1,163,587$0$19.94M1.46%+$19.94M
Agomab Therapeutics NvADS2,733,9261,740,230-993,696$35.49M$19.32M1.41%-$16.17M
Nuvation Bio Inc.CL A(NUVB)3,031,0093,031,0090$17.22M$16.97M1.24%-$242.5K
Adarx Pharmaceuticals Inc0769,345+769,345$0$15.34M1.12%+$15.34M
IDEAYA Biosciences, Inc.(IDYA)640,202381,319-258,883$23.86M$14.65M1.07%-$9.21M
Adc Therapeutics SaSHS11,526,71011,584,552+57,842$12.33M$14.13M1.03%+$1.80M
Solid Biosciences Inc1,948,6951,944,342-4,353$19.47M$14.06M1.03%-$5.41M
Zymeworks Inc.(ZYME)491,654491,6540$12.85M$13.02M0.95%+$172.1K
Obsidian Therapeutics Inc0833,157+833,157$0$11.44M0.84%+$11.44M
BioMarin Pharmaceutical Inc.(BMRN)265,169189,538-75,631$15.17M$11.37M0.83%-$3.80M
Climb Bio Inc1,226,330974,489-251,841$15.99M$11.18M0.82%-$4.81M
Celldex Therapeutics, Inc.(CLDX)433,921321,770-112,151$16.15M$10.43M0.76%-$5.72M
Alx Oncology Hldgs Inc7,392,5047,185,263-207,241$15.30M$9.99M0.73%-$5.31M
Aura Biosciences Inc1,666,6671,552,479-114,188$11.83M$9.75M0.71%-$2.08M
Cogent Biosciences, Inc.(COGT)503,321296,606-206,715$19.48M$9.50M0.70%-$9.98M
CeriBell, Inc.(CBLL)386,786386,7860$7.52M$9.43M0.69%+$1.91M
Odyssey Therapeutics Inc425,000374,510-50,490$7.95M$8.32M0.61%+$369.9K
Xenon Pharmaceuticals Inc.(XENE)229,374191,036-38,338$13.85M$7.10M0.52%-$6.74M
LivaNova PLCSHS(LIVN)93,15484,132-9,022$7.66M$6.44M0.47%-$1.22M
Atara Biotherapeutics Inc441,701636,852+195,151$5.07M$5.41M0.40%+$342.5K
Insmed Incorporated(INSM)51,23442,902-8,332$5.46M$4.90M0.36%-$565.7K
Eupraxia Pharmaceuticals Inc611,400519,881-91,519$4.04M$4.73M0.35%+$689.6K
Dbv Technologies S AADS410,440373,417-37,023$6.73M$4.39M0.32%-$2.34M
Oric Pharmaceuticals Inc362,010292,817-69,193$3.92M$3.94M0.29%+$23.7K
Tcgx Acquisition CorpCL A0299,860+299,860$0$3.75M0.27%+$3.75M
Prime Medicine, Inc.(PRME)1,389,6321,146,860-242,772$5.13M$3.50M0.26%-$1.62M
Invivyd Inc2,597,7592,285,320-312,439$2.27M$1.99M0.15%-$277.8K
Ocular Therapeutix, Inc.(OCUL)0243,954+243,954$0$1.87M0.14%+$1.87M
Ardelyx Inc641,750523,870-117,880$3.27M$1.79M0.13%-$1.48M
Pliant Therapeutics Inc772,126772,1260$880.2K$833.9K0.06%-$46.3K
Establishment Labs Holdings Inc.(ESTA)88,9640-88,964$7.63M$0—-$7.63M
Page 1 of 1